Abiopharma

Destination XL Group, Inc. Reports Fiscal 2025 Fourth Quarter and Full-Year Financial Results

Hillman Outlines Blueprint for Strategic Growth Plans and Long-Term Financial Objectives at Inaugural Investor Day

CATO REPORTS 4Q AND FULL YEAR LOSS

OKYO Pharma Announces Chief Development Officer and Director Acquires Shares

Bre‑B de Colombia supera las 500 millones de transacciones mientras ACI Worldwide y el Banco de la República suben al escenario en Fintech Americas 2026

Lantronix and Unusual Machines Partner to Deliver NDAA-Compliant AI-Autonomous Drone Components for U.S. Defense Programs

Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting

O Bre-B da Colômbia atinge mais de 500 milhões de transações enquanto a ACI Worldwide e o Banco de la República se apresentam no Fintech Americas 2026

Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update

ZIM Updates on Withholding Tax Procedures on March 2026 Cash Dividend